150 related articles for article (PubMed ID: 34956321)
1. Identification of an Autophagy-Related lncRNA Prognostic Signature and Related Tumor Immunity Research in Lung Adenocarcinoma.
Chen H; Hu Z; Sang M; Ni S; Lin Y; Wu C; Mu Y; Liu K; Wu S; Li N; Xu G
Front Genet; 2021; 12():767694. PubMed ID: 34956321
[TBL] [Abstract][Full Text] [Related]
2. A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma.
Lu Y; Luo X; Wang Q; Chen J; Zhang X; Li Y; Chen Y; Li X; Han S
Front Genet; 2022; 13():862741. PubMed ID: 35368663
[No Abstract] [Full Text] [Related]
3. Construction of an immune-related lncRNA signature as a novel prognosis biomarker for LUAD.
Chen H; Shen W; Ni S; Sang M; Wu S; Mu Y; Liu K; Li N; Zhu L; Xu G
Aging (Albany NY); 2021 Aug; 13(16):20684-20697. PubMed ID: 34438369
[TBL] [Abstract][Full Text] [Related]
4. A novel signature based on autophagy-related lncRNA for prognostic prediction and candidate drugs for lung adenocarcinoma.
Gong Z; Li Q; Li J; Xie J; Wang W
Transl Cancer Res; 2022 Jan; 11(1):14-28. PubMed ID: 35261881
[TBL] [Abstract][Full Text] [Related]
5. Identification of an immune-related six-long noncoding RNA signature as a novel prognosis biomarker for adenocarcinoma of lung.
Miao H; Chen D; Li R; Hu J; Chen Y; Xu C; Wen Z
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33324975
[TBL] [Abstract][Full Text] [Related]
6. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.
Yu J; Mao W; Xu B; Chen M
Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306
[TBL] [Abstract][Full Text] [Related]
7. Construction of an algorithm based on oncosis-related LncRNAs comprising the molecular subtypes and a risk assessment model in lung adenocarcinoma.
Chen H; Zhou C; Hu Z; Sang M; Ni S; Wu J; Pan Q; Tong J; Liu K; Li N; Zhu L; Xu G
J Clin Lab Anal; 2022 Jun; 36(6):e24461. PubMed ID: 35476781
[TBL] [Abstract][Full Text] [Related]
8. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma.
Zhao J; Lin X; Zhuang J; He F
Front Genet; 2021; 12():714697. PubMed ID: 34777460
[No Abstract] [Full Text] [Related]
9. An autophagy-related long non-coding RNA prognostic model and related immune research for female breast cancer.
Chen J; Li X; Yan S; Li J; Zhou Y; Wu M; Ding J; Yang J; Yuan Y; Zhu Y; Wu W
Front Oncol; 2022; 12():929240. PubMed ID: 36591508
[TBL] [Abstract][Full Text] [Related]
10. The Prognostic and Molecular Landscape of Autophagy-Related Long Noncoding RNA in Colorectal Cancer.
Sun Y; Cao X; Guo Y; Liu B; Zhang Y
Biomed Res Int; 2022; 2022():5614915. PubMed ID: 35097120
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis-Related Signature Predicts Prognosis and Immune Microenvironment Infiltration in Lung Adenocarcinoma.
Zou X; He R; Zhang Z; Yan Y
Front Genet; 2022; 13():818403. PubMed ID: 35571020
[TBL] [Abstract][Full Text] [Related]
12. Identification and Validation of Three Autophagy-Related Long Noncoding RNAs as Prognostic Signature in Cholangiocarcinoma.
Liu YJ; Hounye AH; Wang Z; Liu X; Yi J; Qi M
Front Oncol; 2021; 11():780601. PubMed ID: 34926294
[TBL] [Abstract][Full Text] [Related]
13. Development of Prognostic Indicator Based on Autophagy-Related lncRNA Analysis in Colon Adenocarcinoma.
Zhou W; Zhang S; Li HB; Cai Z; Tang S; Chen LX; Lang JY; Chen Z; Chen XL
Biomed Res Int; 2020; 2020():9807918. PubMed ID: 32964050
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
15. Construction of a prognostic signature of autophagy-related lncRNAs in non-small-cell lung cancer.
Zhang X; Cao Y; Chen L
BMC Cancer; 2021 Aug; 21(1):921. PubMed ID: 34391383
[TBL] [Abstract][Full Text] [Related]
16. A Seven-Long Non-coding RNA Signature Improves Prognosis Prediction of Lung Adenocarcinoma: An Integrated Competing Endogenous RNA Network Analysis.
Li R; Han K; Xu D; Chen X; Lan S; Liao Y; Sun S; Rao S
Front Genet; 2020; 11():625977. PubMed ID: 33584817
[TBL] [Abstract][Full Text] [Related]
17. Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma.
Wu G; Wang Q; Zhu T; Fu L; Li Z; Wu Y; Zhang C
Front Genet; 2021; 12():681277. PubMed ID: 34306024
[TBL] [Abstract][Full Text] [Related]
18. A ferroptosis-related gene signature predicts overall survival in patients with lung adenocarcinoma.
Gao X; Tang M; Tian S; Li J; Liu W
Future Oncol; 2021 Apr; 17(12):1533-1544. PubMed ID: 33432837
[TBL] [Abstract][Full Text] [Related]
19. Identification of a long non-coding RNA signature for predicting prognosis and biomarkers in lung adenocarcinoma.
Yu X; Zhang Y
Oncol Lett; 2020 Apr; 19(4):2793-2800. PubMed ID: 32218832
[TBL] [Abstract][Full Text] [Related]
20. Identification of a Gene Signature Closely Related to Immunosuppressive Tumour Microenvironment Predicting Prognosis of Patients in EGFR Mutant Lung Adenocarcinoma.
Li J; Li H; Zhang C; Zhang C; Jiang L; Wang H; Liu H
Front Oncol; 2021; 11():732841. PubMed ID: 34631565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
